New Key Statistics Module, Z-Score and F-Score
OTCPK:BIOLQ Key Ratios
| Market Cap $ M | 0.17 |
| Enterprise Value $ M | 9.57 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 46.00 |
| EPS (TTM) $ | -10.86 |
| Beneish M-Score | -3.81 |
| 10-y EBITDA Growth Rate % | 36.70 |
| 5-y EBITDA Growth Rate % | 60.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.57 |
| EV-to-EBITDA | -0.67 |
| PEG | -- |
| Shares Outstanding M | 36.60 |
| Net Margin (%) | -41.65 |
| Operating Margin % | -35.84 |
| Pre-tax Margin (%) | -41.56 |
| Quick Ratio | 0.36 |
| Current Ratio | 0.71 |
| ROA % (ttm) | -53.78 |
| ROE % (ttm) | -21,668.17 |
| ROIC % (ttm) | -80.56 |
| Dividend Yield % | -- |
| Altman Z-Score | -15.55 |
BIOLQ Number of Guru Trades
BIOLQ Volume of Guru Trades
Gurus Latest Trades with OTCPK:BIOLQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:BIOLQ is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Biolase Inc Insider Transactions
No Available Data
News about OTCPK:BIOLQ
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers